BRIEF published on 04/16/2025 at 18:05, 1 year 4 months ago Mikron Shareholders Support Board's Proposals at AGM Board Of Directors Annual General Meeting Shareholder Approval Mikron Holding AG Distribution Per Share
PRESS RELEASE published on 04/16/2025 at 18:00, 1 year 4 months ago Mikron shareholders approve all proposals of the Board of Directors Mikron Holding AG shareholders approve all Board proposals at Annual General Meeting, including CHF 0.50 distribution per share. Board members re-elected Board Of Directors Annual General Meeting Shareholders Mikron Holding AG CHF 0.50
BRIEF published on 03/07/2025 at 07:05, 1 year 6 months ago Mikron Holding AG Reports Stable Financial Results for 2024 Operating Profit Net Sales Mikron Holding AG Order Backlog 2024 Financial Results
PRESS RELEASE published on 03/07/2025 at 07:00, 1 year 6 months ago Mikron reports a solid result Mikron Holding AG reports a 1.0% increase in net sales for 2024, with an operating profit of CHF 31.9 million. The company looks ahead to a promising financial year 2025 Operating Profit Net Sales Mikron Holding AG Order Backlog Financial Year 2024
BRIEF published on 01/24/2025 at 07:05, 1 year 7 months ago Mikron Announces 2024 Net Sales of CHF 374.1 Million Automation Net Sales Order Intake Profit Margin Machining Solutions
PRESS RELEASE published on 01/24/2025 at 07:00, 1 year 7 months ago Mikron reports net sales of CHF 374.1 million for 2024 Mikron reports 1.0% increase in net sales to CHF 374.1 million for 2024. Order backlog up 6.5%. Operating profit margin expected around 8.5% for the year Net Sales Order Backlog 2024 Operating Profit Margin Mikron
BRIEF published on 10/30/2024 at 07:05, 1 year 10 months ago Mikron Group Adjusts 2024 Profit Forecast Order Intake Annual Results Mikron Group 2024 Profit Medtech Delay
PRESS RELEASE published on 10/30/2024 at 07:00, 1 year 10 months ago Mikron Group revises its outlook for the full year 2024 Mikron Group revises full-year 2024 outlook, expects decline in net profit due to medtech order delay in the US. Strong order intake and sales performance maintained Mikron Group Full-year Outlook Sales Performance Net Profit Decline Medtech Order Delay
BRIEF published on 07/19/2024 at 07:05, 2 years 1 month ago Mikron Group Reports Continued Strong Performance Automation Solutions Order Intake Mikron Group 2024 Results Profit Margin
PRESS RELEASE published on 07/19/2024 at 07:00, 2 years 1 month ago Mikron Group reports a continued strong performance Mikron Group reports a 7.0% increase in net sales and an operating profit of CHF 14.9 million in the first half of 2024. Order intake slightly declined, yet order backlog increased by 0.7% Operating Profit Net Sales Order Intake Order Backlog Mikron Group
Published on 09/11/2026 at 04:00, 4 hours 51 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 26 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 31 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 17 hours 51 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 08:15, 36 minutes ago EQS-Adhoc: Airbus SE: Airbus commences limited share buyback to support future employee share ownership plan activities and equity-based compensation
Published on 09/11/2026 at 08:02, 48 minutes ago PUMA CCO Matthias Baeumer to step down from Management Board
Published on 09/11/2026 at 07:30, 1 hour 20 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 8 hours 45 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 07:00, 1 hour 51 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 13 hours 21 minutes ago Availability of the 2026 Interim Financial Report
